Israeli study: 4th dose of vaccine provides limited antibodies against omicron
Researchers released new preliminary data Monday suggesting that a fourth dose of either the Pfizer/BioNTech or Moderna vaccines enhanced or increased the number of antibodies to levels higher than what has been seen following a third dose.
In December, Israel started trials for a fourth dose of COVID-19 vaccines for healthy participants. It's the first study of its kind among healthy people receiving a fourth dose.Top health officials like White House medical adviser Dr. Anthony Fauci have already speculated that a fourth dose of an mRNA vaccine may be necessary in the months ahead.
Moderna's CEO said earlier this month that she expected researchers to recommend a fourth dose of her company's vaccine by the fall of 2022.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Case Western converts vending machines to dispense COVID-19 tests for students, staffCase Western Reserve University has converted its vending machines to dispense COVID-19 tests for its students and staff.
Les mer »
‘SNL’ skit blames COVID-19 surge on ‘Spider-Man: No Way Home’: ‘See anything else!’The 'Saturday Night Live' cold open had President Joe Biden (James Austin Johnson) blaming the rise in omicron cases on the December release of 'Spider-Man: No Way Home.'
Les mer »
CDC recommends schools cancel football, band during COVID-19 surgeThe Centers for Disease Control and Prevention has been chastised by some health experts for advising that schools cancel some sports and activities.
Les mer »
Australia has record COVID-19 deaths, hospitals under stress | AP NewsAustralia has reported a record high of COVID-19 deaths. Victoria, its second-largest state, declared an emergency for hospitals in its capital, Melbourne, and several regional hospitals because of staff shortages and a surge in patient admissions.
Les mer »
Researchers zeroing in on ‘why and when’ COVID-19 patients suffer loss of smell and tasteIt’s estimated that about 1.6 million people in the U.S. are still experiencing loss of smell and taste more than six months after contracting COVID-19.
Les mer »